Apolipoprotein CIII reduces proinflammatory cytokine-induced apoptosis in rat pancreatic islets via the Akt prosurvival pathway

Endocrinology

Volumn 152, Issue 8, 2011, Pages 3040-3048

  Størling, Joachim ^a,e   Juntti Berggren, Lisa ^b   Olivecrona, Gunilla ^c   Prause, Michala C ^a   Berggren, Per Olof ^b   Mandrup Poulsen, Thomas ^a,b,d  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APOLIPOPROTEIN C3; CALCIUM CHANNEL; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN KINASE B; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; APOLIPOPROTEIN C-III; APOPTOSIS; CALCIUM; CYTOKINES; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 79960727039     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2010-1422     Document Type: Article

References (38)

1. Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T 2008 Cytokines and β-cell biology: from concept to clinical translation. Endocr Rev 29:334-350 (Pubitemid 351679703)
2. Juntti-Berggren L, Refai E, Appelskog I, Andersson M, Imreh G, Dekki N, Uhles S, Yu L, Griffiths WJ, Zaitsev S, Leibiger I, Yang SN, Olivecrona G, Jörnvall H, Berggren PO 2004 Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes. Proc Natl Acad Sci USA 101:10090-10094 (Pubitemid 38891199)
3. Reverter JL, Sentí M, Rubiés-Prat J, Lucas A, Salinas I, Pizarro E, Pedro-Botet J, SanmartÆ A 1993 Lipoprotein composition in the insulin-deficient non-acidotic phase of type I diabetic patients and early evolution after the start of insulin therapy. Clin Chim Acta 223:113-120 (Pubitemid 24050915)
4. Blackett P, Sarale DC, Fesmire J, Harmon J, Weech P, Alaupovic P 1988 Plasma apolipoprotein C-III levels in children with type I diabetes. South Med J 81:469-473
5. Briones ER, Mao SJ, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA 1984 Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics. Metabolism 33:42-49 (Pubitemid 14224135)
6. Fredenrich A 1998 Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism. Diabetes Metab 24:490-495 (Pubitemid 29048417)
7. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL 1990 Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790-793
8. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J 1994 Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269:23610-23616 (Pubitemid 24293564)
9. Narayanaswami V, Ryan RO 2000 Molecular basis of exchangeable apolipoprotein function. Biochim Biophys Acta 1483:15-36
10. Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC 1995 Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 15:963-971
11. Jong MC, Hofker MH, Havekes LM 1999 Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19:472-484 (Pubitemid 29135144)
12. Gangabadage CS, Zdunek J, Tessari M, Nilsson S, Olivecrona G, Wijmenga SS 2008 Structure and dynamics of human apolipoprotein CIII. J Biol Chem 283:17416-17427
13. Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM 2006 Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation 113:691-700
14. Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM 2006 Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114:681-687 (Pubitemid 44252310)
15. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM 2007 Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase Cα-mediated nuclear factor-κB activation. Arterioscler Thromb Vasc Biol 27:219-225 (Pubitemid 46360402)
16. Sol EM, Sundsten T, Bergsten P 2009 Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells. Lipids Health Dis 8:3
17. Refai E, Dekki N, Yang SN, Imreh G, Cabrera O, Yu L, Yang G, Norgren S, Rössner SM, Inverardi L, Ricordi C, Olivecrona G, Andersson M, Jörnvall H, Berggren PO, Juntti-Berggren L 2005 Transthyretin constitutes a functional component in pancreatic β-cell stimulus-secretion coupling. Proc Natl Acad Sci USA 102:17020-17025 (Pubitemid 41692676)
18. Hokanson JE, Kinney GL, Cheng S, Erlich HA, Kretowski A, Rewers M 2006 Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes. Diabetes 55:834-838 (Pubitemid 43343244)
19. Bengtsson-Olivecrona G, Olivecrona T 1991 Phospholipase activity of milk lipoprotein lipase. Methods Enzymol 197:345-356
20. Nielsen K, Karlsen AE, Deckert M, Madsen OD, Serup P, Mandrup-Poulsen T, Nerup J 1999 β-Cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 48:2324-2332 (Pubitemid 30395423)
21. Eizirik DL, Pavlovic D 1997 Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM? Diabetes Metab Rev 13:293-307
22. Størling J, Zaitsev SV, Kapelioukh IL, Karlsen AE, Billestrup N, Berggren PO, Mandrup-Poulsen T 2005 Calcium has a permissive role in interleukin-1β-induced c-jun N-terminal kinase activation in insulin-secreting cells. Endocrinology 146:3026-3036 (Pubitemid 41002810)
23. Gonzalez E, McGraw TE 2009 The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8:2502-2508
24. Størling J, Binzer J, Andersson AK, Züllig RA, Tonnesen M, Lehmann R, Spinas GA, Sandler S, Billestrup N, Mandrup-Poulsen T 2005 Nitric oxide contributes to cytokine-induced apoptosis in pancreatic β cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 48:2039-2050 (Pubitemid 41416915)
25. Haber EP, Procópio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R 2006 New insights into fatty acid modulation of pancreatic β-cell function. Int Rev Cytol 248:1-41 (Pubitemid 43238169)
26. Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT, RG 2004 Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism 53:1296-1304 (Pubitemid 39222090)
27. Li L, El-Kholy W, Rhodes CJ, Brubaker PL 2005 Glucagon-like peptide-1 protects β cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48:1339-1349 (Pubitemid 41186100)
28. Natalicchio A, De Stefano F, Orlando MR, Melchiorre M, Leonardini A, Cignarelli A, Labarbuta R, Marchetti P, Perrini S, Laviola L, Giorgino F 2010 Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-α (TNFα) and inhibits TNFα-induced apoptosis in insulin-secreting cells. Endocrinology 151:2019-2029
29. Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K, Yoshida M 2008 Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction. Circulation 118:731-742
30. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D 2006 Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proc Natl Acad Sci USA 103:5072-5077
31. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL 2001 Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50:2219-2224 (Pubitemid 33641904)
32. Giannoukakis N, Rudert WA, Trucco M, Robbins PD 2000Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an Iκ B repressor. J Biol Chem 275:36509-36513
33. Chang I, Kim S, Kim JY, Cho N, Kim YH, Kim HS, Lee MK, Kim KW, Lee MS 2003 Nuclear factor κB protects pancreatic β-cells from tumor necrosis factor-α-mediated apoptosis. Diabetes 52:1169-1175 (Pubitemid 36523352)
34. Kim S, Millet I, Kim HS, Kim JY, Han MS, Lee MK, Kim KW, Sherwin RS, Karin M, Lee MS 2007 NF-κ Bprevents β cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 104:1913-1918 (Pubitemid 46239878)
35. Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K, Sacks FM, Yoshida M 2008 Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ Res 103:1402-1409
36. Kiely A, Robinson A, McClenaghan NH, Flatt PR, Newsholme P 2009 Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 β-cell insulin secretion and signal transduction. J Endocrinol 202:365-373
37. Böni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY 2009 Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218-5229
38. Ehses JA, Meier DT, Wueest S, Rytka J, Boller S, Wielinga PY, Schraenen A, Lemaire K, Debray S, Van Lommel L, Pospisilik JA, Tschopp O, Schultze SM, Malipiero U, Esterbauer H, Ellingsgaard H, Rütti S, Schuit FC, Lutz TA, Böni-Schnetzler M, Konrad D, Donath MY 2010 Toll-like receptor 2-deficient mice are protected from insulin resistance and β cell dysfunction induced by a high-fat diet. Diabetologia 53:1795-1806